GPT-4.5 'Orion', Meta's AI App, and AI in Drug Discovery

In this episode, Michelle introduces OpenAI's latest advancement, GPT-4.5 'Orion', providing an overview of its launch, access, and the enhancements it brings to the competitive AI landscape. She then shifts to Meta's launch of a standalone AI app, discussing its functionalities, integration capabilities, and the company's global strategic approach. The episode covers the merger between Recursion and Exscientia, highlighting its potential impact on AI-driven drug discovery. Michelle also reviews recent AI model releases from OpenAI, Anthropic, xAI, and Google. The episode concludes with a wrap-up, summarizing the key points discussed.